Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Language
Publication year range
1.
Anal Biochem ; 668: 115088, 2023 05 01.
Article in English | MEDLINE | ID: mdl-36878338

ABSTRACT

Antithrombin is a key protein of the coagulation system belonging to the serine protease inhibitor family. Antithrombin preparations are used as a therapeutic treatment for patients with decreased antithrombin activity. Elucidating the structural features of this protein is an important part of the control strategy to assure a high quality. This study presents an ion exchange chromatographic method coupled to mass spectrometry capable of characterizing antithrombin post-translational modifications such as N-glycosylation, phosphorylation or deamidation. Furthermore, the method was successfully used to evidence irreversible/inactive conformers of antithrombin which are commonly observed for serine protease inhibitors and referred to as latent forms.


Subject(s)
Antithrombins , Serine Proteinase Inhibitors , Humans , Antithrombins/chemistry , Antithrombins/metabolism , Protein Isoforms , Mass Spectrometry/methods , Chromatography, Ion Exchange/methods
2.
Proteomics ; 14(21-22): 2460-70, 2014 Nov.
Article in English | MEDLINE | ID: mdl-25092234

ABSTRACT

Human factor XI (hFXI) is a 160-kDa disulphide-linked homodimer zymogen involved in the coagulation cascade. Its deficiency results in bleeding diathesis referred to as hemophilia C. hFXI bears five N-glycosylation consensus sites per monomer, N72 , N108 , N335 on the heavy chain and N432 , N473 on the light chain. This study reports the first in-depth glycosylation analysis of hFXI based on advanced MS approaches. Hydrophilic interaction LC and MS characterization and quantification of the N-glycans showed that the two major forms are complex biantennary mono-α2,6-sialylated (A2 S1 , 20%) and bis-α2,6-sialylated structures (A2 S2 , 66%). Minor triantennary structures (A3 S3 F, ∼1.5%; A3 S3 , ∼2%) were also identified. MS analyses of intact hFXI revealed full occupation of two of the three heavy-chain glycosites and almost full-site occupancy of the light chain. Analysis of hFXI glycopeptides by LC-MS/MS enabled site-specific glycan profiling and occupancy. It was evidenced that N335 was not glycosylated and that N72 and N108 were fully occupied, whereas N432 and N473 were occupied at about 92 and 95%, respectively. We also identified a new glycosite of the noncanonical format NXC at N145 , occupied at around 5%. These data provide valuable structural information useful to understand the potential roles of N-glycosylation on hFXI function and could serve as a structural reference.


Subject(s)
Factor XI/chemistry , Polysaccharides/analysis , Amino Acid Sequence , Carbohydrate Sequence , Chromatography, Liquid , Glycosylation , Humans , Molecular Sequence Data , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization , Tandem Mass Spectrometry
3.
Metallomics ; 6(7): 1269-76, 2014 Jul.
Article in English | MEDLINE | ID: mdl-24733507

ABSTRACT

The canonical transient receptor potential 6 (TRPC6) protein is a non-selective cation channel able to transport essential trace elements like iron (Fe) and zinc (Zn) through the plasma membrane. Its over-expression in HEK-293 cells causes an intracellular accumulation of Zn, indicating that it could be involved in Zn transport. This finding prompted us to better understand the role played by TRPC6 in Zn homeostasis. Experiments done using the fluorescent probe FluoZin-3 showed that HEK cells possess an intracellular pool of mobilisable Zn present in compartments sensitive to the vesicular proton pump inhibitor Baf-A, which affects endo/lysosomes. TRPC6 over-expression facilitates the basal uptake of Zn and enhances the size of the pool of Zn sensitive to Baf-A. Quantitative RT-PCR experiments showed that TRPC6 over-expression does not affect the mRNA expression of Zn transporters (ZnT-1, ZnT-5, ZnT-6, ZnT-7, ZnT-9, Zip1, Zip6, Zip7, and Zip14); however it up-regulates the mRNA expression of metallothionein-I and -II. This alters the Zn buffering capacities of the cells as illustrated by the experiments done using the Zn ionophore Na pyrithione. In addition, HEK cells over-expressing TRPC6 grow slower than their parental HEK cells. This feature can be mimicked by growing HEK cells in a culture medium supplemented with 5 µM of Zn acetate. Finally, a proteomic analysis revealed that TRPC6 up-regulates the expression of the actin-associated proteins ezrin and cofilin-1, and changes the organisation of the actin cytoskeleton without changing the cellular actin content. Altogether, these data indicate that TRPC6 is participating in the transport of Zn and influences the Zn storage and buffering capacities of the cells.


Subject(s)
TRPC Cation Channels/biosynthesis , Zinc/metabolism , Actin Depolymerizing Factors/biosynthesis , Cation Transport Proteins/metabolism , Cytoskeletal Proteins/biosynthesis , HEK293 Cells , Homeostasis/drug effects , Humans , Polycyclic Compounds/pharmacology , Proton Pump Inhibitors/pharmacology , TRPC6 Cation Channel
4.
J Biomol Screen ; 19(2): 317-24, 2014 Feb.
Article in English | MEDLINE | ID: mdl-23954930

ABSTRACT

A screening procedure was developed that takes advantage of the cellular normalization by micropatterning and a novel quantitative organelle mapping approach that allows unbiased and automated cell morphology comparison using black-box statistical testing. Micropatterns of extracellular matrix proteins force cells to adopt a reproducible shape and distribution of intracellular compartments avoiding strong cell-to-cell variation that is a major limitation of classical culture conditions. To detect changes in cell morphology induced by compound treatment, fluorescently labeled intracellular structures from several tens of micropatterned cells were transformed into probabilistic density maps. Then, the similarity or difference between two given density maps was quantified using statistical testing that evaluates differences directly from the data without additional analysis or any subjective decision. The versatility of this organelle mapping approach for different magnifications and its performance for different cell shapes has been assessed. Density-based analysis detected changes in cell morphology due to compound treatment in a small-scale proof-of-principle screen demonstrating its compatibility with high-throughput screening. This novel tool for high-content and high-throughput cellular phenotyping can potentially be used for a wide range of applications from drug screening to careful characterization of cellular processes.


Subject(s)
Cell Shape , High-Throughput Screening Assays , Organelles , Cytoskeleton/metabolism , Humans , Image Processing, Computer-Assisted
5.
Appl Environ Microbiol ; 79(19): 5907-17, 2013 Oct.
Article in English | MEDLINE | ID: mdl-23872561

ABSTRACT

Streptomyces lividans TK24 is a strain that naturally produces antibiotics at low levels, but dramatic overproduction of antibiotics occurs upon interruption of the ppk gene. However, the role of the Ppk enzyme in relation to the regulation of antibiotic biosynthesis remains poorly understood. In order to gain a better understanding of the phenotype of the ppk mutant, the proteomes of the wild-type (wt) and ppk mutant strains, grown for 96 h on R2YE medium limited in phosphate, were analyzed. Intracellular proteins were separated on two-dimensional (2D) gels, spots were quantified, and those showing a 3-fold variation or more were identified by mass spectrometry. The expression of 12 proteins increased and that of 29 decreased in the ppk mutant strain. Our results suggested that storage lipid degradation rather than hexose catabolism was taking place in the mutant. In order to validate this hypothesis, the triacylglycerol contents of the wt and ppk mutant strains of S. lividans as well as that of Streptomyces coelicolor M145, a strain that produces antibiotics at high levels and is closely related to S. lividans, were assessed using electron microscopy and thin-layer chromatography. These studies highlighted the large difference in triacylglycerol contents of the three strains and confirmed the hypothetical link between storage lipid metabolism and antibiotic biosynthesis in Streptomyces.


Subject(s)
Anti-Bacterial Agents/biosynthesis , Bacterial Proteins/analysis , Lipid Metabolism , Phosphotransferases (Alcohol Group Acceptor)/metabolism , Proteome/analysis , Streptomyces lividans/enzymology , Streptomyces lividans/metabolism , Electrophoresis, Gel, Two-Dimensional , Gene Deletion , Mass Spectrometry , Phosphotransferases (Alcohol Group Acceptor)/genetics , Streptomyces lividans/genetics
6.
J Vis Exp ; (46)2010 Dec 02.
Article in English | MEDLINE | ID: mdl-21189468

ABSTRACT

To date, most HCA (High Content Analysis) studies are carried out with adherent cell lines grown on a homogenous substrate in tissue-culture treated micro-plates. Under these conditions, cells spread and divide in all directions resulting in an inherent variability in cell shape, morphology and behavior. The high cell-to-cell variance of the overall population impedes the success of HCA, especially for drug development. The ability of micropatterns to normalize the shape and internal polarity of every individual cell provides a tremendous opportunity for solving this critical bottleneck (1-2). To facilitate access and use of the micropatterning technology, CYTOO has developed a range of ready to use micropatterns, available in coverslip and microwell formats. In this video article, we provide detailed protocols of all the procedures from cell seeding on CYTOOchip micropatterns, drug treatment, fixation and staining to automated acquisition, automated image processing and final data analysis. With this example, we illustrate how micropatterns can facilitate cell-based assays. Alterations of the cell cytoskeleton are difficult to quantify in cells cultured on homogenous substrates, but culturing cells on micropatterns results in a reproducible organization of the actin meshwork due to systematic positioning of the cell adhesion contacts in every cell. Such normalization of the intracellular architecture allows quantification of even small effects on the actin cytoskeleton as demonstrated in these set of protocols using blebbistatin, an inhibitor of the actin-myosin interaction.


Subject(s)
Cytological Techniques/methods , Drug Evaluation, Preclinical/methods , Actins/antagonists & inhibitors , Actins/metabolism , Cell Adhesion , Cytoskeleton/drug effects , Cytoskeleton/metabolism , HeLa Cells , Heterocyclic Compounds, 4 or More Rings/pharmacology , Humans , Myosins/antagonists & inhibitors , Myosins/metabolism , Staining and Labeling/methods
7.
Mech Ageing Dev ; 131(11-12): 661-5, 2010.
Article in English | MEDLINE | ID: mdl-20854835

ABSTRACT

Base Excision Repair (BER) is the predominant repair pathway responsible for removal of so-called small DNA lesions such as abasic sites (AP site), uracil (U), 8-oxo-7,8-dihydroguanine (8oxoG), thymine glycol (Tg). In this study, we investigated effect of aging on excision efficacy of several endogenous base lesions and AP sites using an in vitro multiplexed fluorescent approach on support (parallelized oligonucleotide cleavage assay). Human fibroblasts nuclear extracts from 29 donors of different ages were characterized in their ability to simultaneously excise the different lesions. Clearly, three different groups of lesions emerged according to the efficiency of their cleavage: one exhibited very high cleavage efficiency (AP sites and U paired with G), one showed intermediate cleavage efficiency (U paired with A and Tg). The third group included 8oxoG, A paired with 8oxoG, T at CpG site and hypoxanthine (Hx) and displayed poor repair. Aging was significantly associated with modification of excision efficiency for AP sites, uracil, Tg and 8oxoG. Repair rate decreased for the first three lesions and the most drastic effects were observed for repair of U:A. Surprisingly, excision of 8oxoG increased with aging suggesting a completely different regulation or adaptation for the initiation step of this related specific repair pathway.


Subject(s)
Aging/genetics , DNA Repair , Fibroblasts/metabolism , Skin/metabolism , Adult , Age Factors , Aged , Cell Extracts/chemistry , Female , Fibroblasts/chemistry , Fibroblasts/radiation effects , Guanine/analogs & derivatives , Guanine/metabolism , Humans , Middle Aged , Skin/cytology , Skin/radiation effects , Ultraviolet Rays , Uracil/metabolism , Young Adult
8.
DNA Cell Biol ; 23(5): 283-92, 2004 May.
Article in English | MEDLINE | ID: mdl-15169608

ABSTRACT

It is now recognized that atherosclerosis complications are related to the unstable character of the plaque rather than its volume. Vulnerable plaques often contain a large lipid core, a reduced content of smooth muscle cells, and accumulation of inflammatory cells. Colocalization of macrophages and active matrix metalloproteinases (MMPs) is likely relevant for atherosclerotic lesion disruption. Nevertheless, MMP activity and regulation by cardiovascular drugs remains poorly defined. In this study, we evaluated the effects of avasimibe, fluvastatin, and peroxisome proliferator-activated receptor (PPAR) ligands on 92-kDa gelatinase B (MMP-9) secretion by human THP-1 macrophages. THP-1 macrophages were treated with compounds for 48 h, and secreted MMP-9 protein was quantified by immunoassay. Avasimibe, fluvastatin, and PPARalpha agonists (fenofibric acid and Wy-14643) significantly reduced, in a concentration-dependent manner, MMP-9 protein (up to 67 +/- 5% for fenofibric acid). In these assays, the PPARgamma selective agonist rosiglitazone displayed a lower efficacy than other compounds. Enzymatic activity of MMP-9 was also decreased by all cardiovascular drugs tested. MMP-9 protein/activity inhibition by cardiovascular drugs was due, at least in part, to a decrease in MMP-9 mRNA. These results show that THP-1 macrophages could be an useful cellular model to investigate effects of compounds on plaque vulnerability through MMP-9 activity.


Subject(s)
Cardiovascular Agents/pharmacology , Fenofibrate/analogs & derivatives , Macrophages/drug effects , Macrophages/enzymology , Matrix Metalloproteinase Inhibitors , Acetamides , Acetates/pharmacology , Anilides/pharmacology , Cell Line , Enzyme Inhibitors/pharmacology , Fatty Acids, Monounsaturated/pharmacology , Fenofibrate/pharmacology , Fluvastatin , Humans , Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacology , Indoles/pharmacology , Lipoproteins, LDL/pharmacology , Macrophages/cytology , Matrix Metalloproteinase 9/genetics , Matrix Metalloproteinase 9/metabolism , Mevalonic Acid/pharmacology , Monocytes/drug effects , Monocytes/metabolism , Pyrimidines/pharmacology , Receptors, Cytoplasmic and Nuclear/agonists , Receptors, Cytoplasmic and Nuclear/antagonists & inhibitors , Receptors, Cytoplasmic and Nuclear/metabolism , Rosiglitazone , Sterol O-Acyltransferase/antagonists & inhibitors , Sulfonamides , Sulfonic Acids/pharmacology , Tetradecanoylphorbol Acetate/pharmacology , Thiazolidinediones/pharmacology , Tissue Inhibitor of Metalloproteinase-1/drug effects , Tissue Inhibitor of Metalloproteinase-1/metabolism , Transcription Factors/agonists , Transcription Factors/antagonists & inhibitors
SELECTION OF CITATIONS
SEARCH DETAIL
...